results of this method and those obtained with L-cystine-di-4' -nitroanilide as substrate was 0.97. During pregnancy, the placenta releases cystine aminopeptidase (CAS; oxytocinase)1 into the maternal circulation.
Serum CAS activity is low for the first 26 weeks, but then rises gradually to a maximum at or about term. In complicated pregnancies the latter rise is frequently inadequate and erratic. Evidence is accumulating of the value of detecting deviations from the normal pattern in the prognosis and treatment of abnormal pregnancies (1) (2) (3) , although the number of cases studied so far is inadequate to establish complete correlation of activity patterns with fetal welfare. This is owing partly to difficulties that have attended estimation of the enzyme activity.
In comparison with determination of total urinary estrogens or pregnandiol, a test for monitoring placental function that is applicable to serum has the advantage of ease of collection. For this reason, perhaps, measurement of oxytocinase has received increasing attention recently (4) (5) (6) (7) (8) , and we now report a simple and rapid kinetic method of assay. Cystine aminopeptidase degrades oxytocin by cleaving the cystine-tyrosine linkage. Tuppy et al. demonstrated that the enzyme will also cleave 2-naphthylamine (9) and 4-nitroaniline (10) from the corresponding synthetic amides of L-cystine. Both reactions have been used to estimate the enzyme by following the rate at which the arylamine is liberated; both assays have been developed to the point of automation (5, 7, 8) ; and both suffer disadvantages associated with the substrates.
Manufacture and use of L-cystine-di-2'-naphthylamide involves exposure to a carcinogenic amine, 2-naphthylamine, whereas the corresponding di-4'-nitroanilide is difficult to prepare in a high and reproducible state of purity. That CAS will also hydrolyze peptides of S-benzyl-L-cysteine was discovered by Berankova et al. (11) (12) (13) , and was exploited for assay purposes by Wintersberger et al. (14) with the introduction of the hazardous S-benzyl-L-cysteine-2'-naphthylamide as a substrate.
In his extensive review of CAS determination, Tuppy 
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2-Methoxyethanol
concentration.
Wintersberger et al. (14) discovered when using S-benzyl-L-cysteine-2'-naphthylamide as substrate, that incorporation of 2-methoxyethanol into the assay solution enhanced CAS activity; they reported a 50% activity increase in the presence of 10-15% of solvent. The same effect has now been found with the 4'-nitroanilide, except that inhibition occurred at concentrations above 12.0% ( Figure 2 ). The optimum proportions lay between 7 and 10%, and 8.33% of the final reaction volui#{241}e was used in all subsequent assays. Its presence helps to solubilize the substrate. has not been studied systematically. Phosphate is generally used, and a 50 millimolar concentration was chosen for this work. CAS activity against this substrate was studied over the pH range 6.88-7.59 and, in agreement with many previous similar determinations, the enzyme was found to exhibit a broad pH maximum ( Figure  3 ). The final choice of pH 7.2 represented a compromise close to the optimum for most sera. It should be noted that this pH is that of the phosphate buffer alone, and that the "pH" recorded by a glass electrode rises to a value of about 7.4 after addition of 2-methoxyethanol in a final concentration of 8.3 ml! 100 ml.
Optimum substrate concentration.
The plot of en- if the substrate is added to the buffer before the serum, or if the buffered serum is much below 37#{176}C at the moment the substrate is added. The protein content of the serum exerts a marked solubilizing affect upon the substrate, and much higher concentrations could be reached by increasing the protein concentration in the assay artificially by adding bovine serum albumin.
However, this practice was abandoned when it was found that different batches of albumin depressed the activity of the enzyme to various extents. The same problem was encountered by Small and Watkins (16) with L-cystine-di-4'-nitroanilide as substrate, and overcome by incorporation of "Triton X-100" (3 ml/liter) in the, assay solution; in our hands, this surfactant diminished the enzyme activity. Turbidity is avoided by following exactly the procedure below, although the methodology may require modification for those machines that do not have the facility, as does the LKB 8600, for pre-incubating cuvets.
In manual assays it is convenient to dispense the substrate as a solution in the 2-methoxyethanol.
However, this solvent attacks the plastic pump of the LKB machine and hence in the automated procedure the substrate was added as a solution in 10 millimolar hydrochloric acid. tical differences in the performances of the various batches, the actual differences between the mean values can be seen to be too small to invalidate clinical significance.
Assay Procedure, LKB Method
The correlation between results of this assay and those of the method using L-cystine-di-4'-nitroanilide was established in a series of duplicate determinations on 39 sera of various activities ( Figure  6 ); the correlation coefficient was 0.97.
Observed Values
This assay is now being used routinely by one of us (J. E. T.) to monitor pregnant women from the Worthing area of Sussex. The number of cases followed through to delivery so far is small, and it is premature to attempt to define normal values. To illustrate results given by the assay, mean values obtained at the various stages of pregnancy to date are plotted in Figure 7 , together with the standard deviations and the number of patients in each sample. A trend can be observed toward the pattern of CAS values established by earlier work (1, 2, 16) , but the number of results is insufficient to delineate normal ranges for the assay.
Discussion
The procedures described in this paper offer a method for determining serum CAS activity that is experimentally simple and rapid. For the assay described in this paper to have relevance to the management of pregnancy, it is essential to demonstrate that the enzyme hydrolyzing Sbenzyl-L-cysteine-4'-nitroanilide is, in fact, cysteine aminopeptidase.
The uncertainty is due to the presence in all sera of another protease, leucine aminopeptidase (LAS), and because neither CAS or LAS is completely selective in hydrolytic action toward amino acid derivatives.
Thus, CAS also hydrolyzes leucine-4'-nitroanilide (10), and LAS slowly attacks all the existing cystine derivatives used for assaying CAS (15 (20) and for the chemical assay in which L-cysteine-di-2'-naphthylamide is used (21). S-Benzyl-L-cysteine-4'-nitroanilide is thus appreciably more specific for CAS than the corresponding 2'-naphthylamide, which, in the hands of Wintersberger et al. (14) , recorded an increase of only 30-50 fold in proteolysis throughout the pregnancy. This assay facilitates routine screening of pregnancy cases for CAS activity and may lead to a better understanding of its clinical significance.
